Global Disposable Bioreactors Market Analysis and Forecast Report 2021-2028 – Growing Acceptance of Subs by Small Businesses and Startups –



DUBLIN – (BUSINESS WIRE)–The “Disposable Bioreactors Market Size, Share and Trend Analysis Report by Product, by Type, by Cell Type, by Molecular Type, by Application, by End Use, by Type of Use, by Region, and Segment Forecasts, 2021-2028” Report was added to to offer.

The global single-use bioreactor market is forecast to reach $ 7.76 billion by 2028 and grow at a CAGR of 17.0% from 2021 to 2028

An increasing demand for single-use bioreactors, combined with the rapidly growing demand for biopharmaceutical products, leads to considerable investments in this area. The COVID-19 outbreak has created significant demand for single-use bioreactors as there is a great demand for large-scale vaccine production worldwide.

Continuous strategic initiatives by emerging and established market units to expand capacities are expected to have a positive impact on market growth. For example, in July 2021, Cytiva and Pall Corporation announced plans to expand their manufacturing capabilities and services around the world as they invest over $ 300 million in single-use technology and cell growth bioreactor bags used to manufacture syringe filters and bespoke drugs for research .

An increase in biopharmaceutical research and development also has a significant impact on market growth. Applications of single-use bioreactors in the manufacture of COVID-19 vaccines are driving industrial growth. Because the vaccine development process is complex, key companies work with research institutes on different fronts, such as:

North America dominated the market in 2020 due to the increasing adoption of SUBs coupled with the presence of key biopharmaceutical and biotechnology industries. Asia Pacific is projected to grow at the fastest CAGR over the forecast period, with China being the largest country contributing to the market growth.

Highlights of the Disposable Bioreactors Market Report

  • In terms of the product, single-use bioreactor systems had the largest share of sales in 2020. The widespread acceptance of SUB systems and technological advances have driven the growth of the segment

  • Typically, stirred tank bioreactors were leaders in the market in 2020. They have a high level of penetration among end users, which has resulted in significant revenue generation throughout the forecast period

  • According to cell type, the mammalian cell segment had the largest share of sales in 2020. Mammalian cell cultures play a critical role in the manufacture of biopharmaceutical products

  • In terms of application, the Research & Development segment had the largest share of sales in 2020. The segment shows a high level of use of single-use bioreactors as several biopharmaceutical companies and research institutes have switched to SUBs

  • The end-use segment of CROs and CMOs dominated the market in 2020. Various CMOs are adding single-use system bioreactors to increase commercial production capacity. This has resulted in a number of CMOs becoming commercial product manufacturers. The COVID-19 pandemic has had a positive impact on contract research and contract manufacturing. The segment is experiencing significant growth due to the move to COVID-19 vaccines and therapeutic manufacturing

  • In 2020, the laboratory-scale production uses segment had the largest share of sales due to a large number of research and development programs

Market dynamics

Market driver analysis

  • Growing acceptance of subs by small businesses and startups

  • Reduction of automation complexity

  • Reduction of energy and water consumption

  • Increasing research in the biopharmaceutical market

  • Technological advances in subs

Analysis of the market restrictions

  • Regulatory Concerns About Single Use Bioreactors

  • Market opportunity analysis

  • Patent expiration

Analysis of the market challenges

  • Sterility concerns when using single-use bioreactors

  • Requirements for compatible and GMP-certified sensors

  • Implementation in the workflow of single-use bioreactors

  • Market penetration and growth prospects for the product, 2020 (in MILLION USD)

Impact of the Covid-19 Pandemic on the Global Disposable Bioreactor Market

  • Short term effects

  • Long-term adaptation

  • Bottlenecks in the supply chain

Analysis of the business environment

  • SWOT analysis; By factor (political & legal, economic and technological)

  • Porter’s Five Forces Analysis

Competitive landscape

  • Recent developments and impact analysis by key market players

  • Company assignment

  • List of potential end users

  • List of aspiring players

  • Marker distinguishing features

  • Competitive dashboard analysis

  • Regional network map

Mentioned companies

  • ABEC, Inc.

  • Able Corporation & Biot Corporation

  • bbi-biotech GmbH

  • Cellexus

  • Celltainer Biotech BV

  • Danaher

  • Distek Inc.

  • Eppendorf AG

  • G&G Technologies, Inc.

  • Getinge AB

  • Merck KGaA

  • Satake Chemical Equipment Mfg., Ltd.

  • PBS Biotech, Inc.

  • Sartorius AG

  • Solida Biotech GmbH

  • Stobbe Pharma GmbH

  • Thermo Fisher Scientific, Inc.

For more information on this report, see



Comments are closed.